Intracellular calcium levels ([Ca 2ϩ ] i ) and glucose uptake are central to cardiomyocyte physiology, yet connections between them have not been studied. We investigated whether insulin regulates [Ca 2ϩ ] i in cultured cardiomyocytes, the participating mechanisms, and their influence on glucose uptake via SLC2 family of facilitative glucose transporter 4 (GLUT4).
Primary neonatal rat cardiomyocytes were preloaded with the Ca 2ϩ fluorescent dye fluo3-acetoxymethyl ester compound (AM) and visualized by confocal microscopy. Ca 2ϩ transport pathways were selectively targeted by chemical and molecular inhibition. Glucose uptake was assessed using [ 3 H]2-deoxyglucose, and surface GLUT4 levels were quantified in nonpermeabilized cardiomyocytes transfected with GLUT4-myc-enhanced green fluorescent protein.
Insulin elicited a fast, two-component, transient increase in [Ca 2ϩ ] i . Nifedipine and ryanodine prevented only the first component. The second one was reduced by inositol-1,4,5-trisphosphate (IP 3 )-receptor-selective inhibitors (xestospongin C, 2 amino-ethoxydiphenylborate), by type 2 IP 3 receptor knockdown via small interfering RNA or by transfected G␤␥ peptidic inhibitor ␤ARKct. Insulin-stimulated glucose uptake was prevented by bis(2-aminophenoxy)ethane-N,N,NЈ,NЈ-tetra-acetic acid-AM, 2-amino-ethoxydiphenylborate, and ␤ARK-ct but not by nifedipine or ryanodine. Similarly, insulindependent exofacial exposure of GLUT4-myc-enhanced green fluorescent protein was inhibited by bis(2-aminophenoxy)ethane-N,N,NЈ,NЈ-tetra-acetic acid-AM and xestospongin C but not by nifedipine. Phosphatidylinositol 3-kinase and Akt were also required for the second phase of Ca 2ϩ release and GLUT4 translocation. Transfected dominant-negative phosphatidylinositol 3-kinase ␥ inhibited the latter.
In conclusion, in primary neonatal cardiomyocytes, insulin induces an important component of Ca C ardiac muscle is an energy-consuming tissue that requires constant supply of oxygen and metabolic fuels to maintain contractile function. Under physiological conditions, fatty acids are major metabolic substrates for the heart. However, up to 30% of myocardial ATP is generated by glucose and lactate, with lesser contribution from ketones and amino acids. Although glucose is not the major metabolic substrate in the beating heart, it is paramount in several pathological conditions (1) .
Insulin is an important regulator of cardiac size and metabolism, and the absence of insulin receptors impedes the switch of cardiac substrate utilization from glucose to fatty acids (2) . Like skeletal muscle cells and adipocytes, most insulin actions in cardiomyocytes have been linked to activation of two canonical signaling pathways: the phosphatidylinositol 3-kinase (PI3K)-protein kinase Akt pathway and the Ras-MAPK pathway (3) . In addition, a Cbl-CAP-TC10 pathway has also been described in cardiac muscle (4) . Interestingly, the insulin receptor has also been reported to activate heterotrimeric G proteins in adipocytes and fibroblasts (5, 6) .
Glucose enters cardiomyocytes via the SLC2 family of facilitative glucose transporters (GLUTs) (7) . The most abundant GLUT in the heart is GLUT4, essential for insulin-dependent glucose uptake in this tissue (8) . Insulindependent gains in GLUT4 at the cell surface have been detected in cardiac tissue by immunocytochemistry, subcellular fractionation, and surface photolabeling (9 -12) . In the heart, there is also significant expression of GLUT1, which under certain circumstances is responsible for a significant component of cardiac glucose uptake (13) .
In skeletal muscle, insulin-dependent signals regulating GLUT4 translocation include IRS-1, class IA PI3K, Akt, AS160, and atypical protein kinase C (14) . In contrast, beyond PI3K, the insulin signals regulating GLUT4 translocation and glucose uptake in cardiac cells remain to be defined (15) . In this context, it is interesting to inquire whether intracellular calcium levels ([Ca 2ϩ ] i ) contribute to regulating glucose uptake. In adipocytes, interfering with [Ca 2ϩ ] i decreased insulin-stimulated glucose uptake and Akt phosphorylation (16) , and, in skeletal muscle fibers, Ca 2ϩ influx was found important for full stimulation of glucose uptake (17, 18) . Surprisingly, despite the prominent regulation of Ca 2ϩ in cardiomyocyte function (19) , its participation in the metabolic actions of insulin in this tissue is unknown. In isolated adult cardiomyocytes, insulin stimulates voltage-activated L-type Ca 2ϩ channels (LTCCs) (20) and Na ϩ -Ca 2ϩ exchange (21) , but whether this regulates glucose uptake has not been explored.
Cultured neonatal cardiomyocytes are an interesting in vitro model to study regulation of glucose uptake by insulin because, at approximately the perinatal period, the predominant metabolism of the heart shifts from non-oxidative glucose utilization to fatty acids oxidation (22) . This shift is associated with changes in expression of a number of regulatory proteins of glucose and fatty acids metabolism (23, 24) . Importantly, GLUT4 is already expressed in neonatal cardiomyocytes (12, 24) and represents up to 40% of the adult content (25) . In these cells, we have observed a contribution of both IGF-1 and testosterone to calcium homeostasis (26, 27) .
Here we show that, at physiological doses, insulin induces a transient [Ca 2ϩ ] i increase into neonatal rat cardiomyocytes, revealed by a fluorescent Ca 2ϩ indicator. The signal has two components: one dependent on extracellular Ca 2ϩ influx and a second one dependent on Ca 2ϩ release from sarcoendoplasmic reticulum (SER) stores. Notably, the latter contributes to the insulin-dependent increase in glucose uptake through internal GLUT4 vesicle translocation and fusion with the plasma membrane. Finally, we established the participation of a G protein, PI3K␥ and 1,4,5-inositol-triphosphate (IP 3 ) receptor (IP 3 R) axis in the mechanism leading to the Ca 2ϩ signal and GLUT4-mediated increase in glucose uptake.
Materials and Methods

Animals
Rats were bred in the Animal Breeding Facility, Faculty of Chemical and Pharmaceutical Sciences, University of Chile (Santiago, Chile). Studies were approved by the Institutional Bioethical Committee, Faculty of Chemical and Pharmaceutical Sciences, University of Chile, in accordance with the National Institutes of Health Guide for the Care and Use of Laboratory Animals (28) .
Primary culture of neonatal rat cardiomyocytes
Cardiomyocytes were prepared from hearts of 1-to 3-d-old Sprague Dawley rats as described previously (29) . Cultured cardiomyocytes were more than 95% pure based on ␤-myosin heavy chain expression. Serum was removed 24 h before insulin (Novo Nordisk Pharma, Hellerup, Denmark) stimulation. Under these conditions, cardiomyocytes do not show spontaneous Ca 2ϩ oscillations.
Recombinant adenoviruses
Adenoviruses (Ad) for ␤ARK-ct (Ad␤ARK-ct), green fluorescent protein (GFP) (AdGFP), and an empty construct (AdEmpty) were a gift from Dr. W. J. Koch (Duke University, Durham, NC). Ad␤ARK-ct leads to expression of the C-terminal portion of ␤-adrenergic receptor kinase that binds G␤␥ subunits and behaves as dominant-negative inhibitor of G␤␥ signaling (30) . Transduction efficiency was more than 95% monitored with AdGFP.
Intracellular Ca
2؉ levels [Ca 2ϩ ] i was determined in cardiomyocytes preloaded with fluo3-acetoxymethyl ester compound (AM) as described previ-ously (26) . Insulin was added directly to the microscope chamber, and fluorescence images were collected every 0.985 s and then analyzed with NIH ImageJ software.
Glucose uptake
Cardiomyocytes were rinsed twice with HEPES-buffered saline containing either 2 mM CaCl 2 or 2 mM EGTA as indicated and maintained in this condition for 1 h. Inhibitors were added during the last 30 min and insulin during the last 10 min. Ad transduction was performed 24 h before insulin stimulation. Glucose uptake was measured using 10 M [ 
Transfections and immunofluorescence microscopy
Cardiomyocytes were transfected with 2 g GLUT4-mycenhanced GFP (eGFP) (32), wild-type (WT) PI3K␥, kinase-dead (KD) PI3K␥, myristoylated (myr) PI3K␥, Akt-myr (donated by Dr. T. R. Jackson, University of Newcastle, Newcastle, UK), or tetanus toxin (TeTx) light chain (33) using 2 l/ml Lipofectamine 2000 (Invitrogen, Carlsbad, CA). Transfection efficiency was 7%. Type 2 IP 3 R mRNA was knocked down using 100 nM of a mix of four different small interfering (si) IP 3 R2 (Thermo Fisher Scientific, Waltham, MA) with 1 l/ml DharmaFECT (Thermo Fisher Scientific). siRNA to the unrelated protein emerin (Sigma-Proligo) served as control. Plasmids or siRNA-treated cells were incubated 24 or 72 h before experiments, respectively. Cell surface GLUT4-myc-eGFP was determined as described previously (32) , from the ratio of surface myc signal to total cellular eGFP fluorescence in each cell.
Membrane potential determinations
Membrane potential was recorded from single, cultured cardiomyocytes using the perforated patch configuration of the whole-cell recording technique. Patch electrodes were formed from thin-walled borosilicate capillary glass using a horizontal puller and filled with the following: 120 mM K-gluconic acid, 20 mM KCl, 8 mM NaCl, 1 mM MgCl 2 , 10 mM HEPES, and 240 mg/ml amphotericin B (pH 7.4), tip resistance of approximately 2.5 mW. Experiments were performed with the cells bathed in an extracellular solution containing the following (in mM): 145 NaCl, 5 KCl, 1 MgCl 2 , 2.5 CaCl 2 , 10 HEPES, and 5.6 glucose (pH 7.4). The electrode was sealed onto the membrane of a cardiomyocyte with gentle suction, and membrane potential recordings began when the amphotericin B in the pipette had perforated the membrane under the patch to an access resistance less than 40 mW (usually 5-15 min). Membrane potential was recorded in current-clamp mode using an EPC-7 patch-clamp amplifier (HEKA, Lambrecht/Pfalz, Germany) and a Digidata 1200B data acquisition system (Molecular Devices, Sunnyvale, CA), at an acquisition rate of 200 samples/s. Insulin was added to the bath solution from a stock solution in H 2 O, after recording basal membrane potential for at least 3 min. In some experiments, the amplifier was switched to voltage-clamp mode to record voltagedependent membrane currents in response to families of depolarizing voltage pulses, before and after addition of insulin.
Statistical analysis
Results are expressed as mean Ϯ SD of the number of independent experiments indicated (n) and subjected to ANOVA, and comparisons between groups were performed using a protected Tukey's t test assigning P Ͻ 0.05 as limit of statistical significance. Experiments illustrated are representative of assays performed on at least three separate occasions.
Results
Insulin induces a biphasic [Ca 2؉ ] i increase in cultured cardiomyocytes
Changes in [Ca 2ϩ ] i were determined in cardiomyocytes preloaded with fluo3-AM. Quiescent cardiomyocytes, maintained in Ca 2ϩ -containing media, exhibited basal intracellular Ca 2ϩ levels with an average peak fluorescence of 24 Ϯ 15 [⌬F/F] ϫ 100 (n ϭ 10) relative to the first 10 s mean basal reading (Supplemental Fig. 1 , A and C, published on The Endocrine Society's Journals Online web site at http://endo.endojournals.org), whereas in Ca 2ϩ -free media, the basal peak fluorescence was 8 Ϯ 1 [⌬F/F] ϫ 100 (n ϭ 10) (Supplemental Fig. 1 , B and C). These values correspond to 5 min of recording.
In cardiomyocytes maintained in Ca 2ϩ -containing media, insulin (10 and 100 nM) induced a transient [Ca 2ϩ ] i increase that exhibited two kinetically distinguishable phases ( ] i in practically all the cells analyzed but showed different Ca 2ϩ kinetics profile, possibly related with a nonspecific activation of other receptors (data not shown). We chose 10 nM insulin for all the following experiments because it is near physiological concentration that induced a consistent, large [Ca 2ϩ ] i response, ensuring specificity. In either case, the magnitude of these changes in [Ca 2ϩ ] i is comparatively smaller than those occurring during normal heart beat and hence would not be expected to modify cardiac function.
To confirm that insulin also caused release of Ca 2ϩ from intracellular stores, we first depleted SER Ca 2ϩ using thapsigargin (a SER Ca 2ϩ -ATPase inhibitor). In the absence of extracellular Ca 2ϩ , thapsigargin induced a rapid increase in intracellular fluorescence. Subsequent addition of caffeine or insulin did not evoke any increase in [Ca 2ϩ ] i levels (Supplemental Fig. 1E ). These results indicate that the insulin-induced [Ca 2ϩ ] i gain in cardiomyocytes maintained in Ca 2ϩ -free media is mainly attributable to Ca 2ϩ release from thapsigargin-sensitive internal stores. To test whether the effect of 10 nM insulin was through its receptors, cardiomyocytes were preincubated with genistein (tyrosine kinase receptor inhibitor). Genistein blocked the insulin-dependent increase in [Ca 2ϩ ] i in both the presence or absence of extracellular Ca 2ϩ (Supplemental Fig. 1F ). These data suggest that the increase in [Ca 2ϩ ] i induced by insulin depend on the activation of insulin receptor. rise observed in cardiomyocytes, we measured membrane potential from individual cultured cardiomyocytes using the perforated patch recording method. Under basal conditions, the majority of cardiomyocytes fired simple or compound action potentials of variable frequency and duration from a hyperpolarized resting potential (Supplemental Fig. 2A, left and middle panels) . The remaining cells displayed a stable, hyperpolarized membrane potential and fired very few action potentials (Supplemental Fig. 2A, right panel) . Insulin induced a transient depolarization and volley of action potentials, after which the membrane potential returned to its baseline level (Supplemental Fig.  2B ). Another type of response observed was a gradual but sustained depolarization of the membrane, reaching levels between Ϫ40 and Ϫ20 mV (data not shown). Cardiomyocytes displaying this response ceased firing action potentials, probably as a result of inactivation of voltage-dependent sodium channels at the depolarized membrane potentials. These responses were not artifacts caused by mechanical disruption of the preparation during the addition of solution to the static bath, because such responses were not seen when vehicle alone was added to the bath solution (n ϭ 6). These results support the idea that the nifedipine-sensitive, fast Ca 2ϩ component induced by insulin is attributable to calcium influx through LTCCs after plasma membrane depolarization of cardiomyocytes.
There are two major routes of Ca 2ϩ efflux from SER, one mediated by a channel inhibitable by ryanodine [channel hence termed ryanodine receptor (RyR)], the other by a channel activated by IP 3 (IP 3 R). The RyR is tightly coupled to activation by surface LTCC for excitation-contraction coupling (34) . In cells preincubated with ryanodine (50 M) and then placed in Ca 2ϩ -containing media, the peak of first-phase insulin-induced [Ca 2ϩ ] i transient was both reduced and delayed (Fig. 1E) . These results suggest that the first phase of the insulin-induced [Ca 2ϩ ] i transient requires both nifedipine-sensitive entry of external -free media (Fig. 1F) .
The second phase of insulindependent [Ca
2؉
] i rise is mediated by Ca 2؉ efflux through IP 3 R From Fig. 1 , it emerges that the second phase of insulin-dependent [Ca 2ϩ ] i transient occurs through Ca 2ϩ release into the cytosol from intracellular stores but is not mediated by RyR. To evaluate Ca 2ϩ release through IP 3 R channels, we used two well-described inhibitors, 2-amino-ethoxydiphenylborate (2-APB) and xestospongin C (26), as well as knockdown of the type 2 IP 3 R via siRNA (for knockdown efficiency, see Supplemental Fig. 3 ). Remarkably, all three maneuvers completely inhibited the insulininduced [Ca 2ϩ ] i increase (Fig. 2, A-C -free media with the respective inhibitors and then stimulated with 10 nM insulin. Fluo3-AM and corresponding inhibitors were added during preincubation and during stimulation. Fluorescence images were acquired, and relative fluorescence was calculated as described in Figure 1 in Ca 2ϩ -free media (Fig. 2E) (Fig. 2G) , supporting the participation of PLC in this response.
The results in Fig. 3 reveal a novel pathway from the insulin receptor to eventual activation of a putative G protein whose ␤␥ subunits and PLC contribute to opening IP 3 R. Given that insulin classically activates PI3K, we (Fig.  2H) , raising the possibility that such PI3K may be PI3K␥, a known upstream activator of PLC (35) (see below).
The above experiments were performed in Ca 2ϩ -free medium for easier visualization of the second phase, having eliminated the first phase of Ca 2ϩ influx. Parallel experiments in Ca 2ϩ -containing media rendered comparable results (Supplemental Fig. 4 -release response (Supplemental Fig. 5, A-C) . These results suggest that unrelated signaling pathways are perfectly operative when the insulindependent Ca 2ϩ signals are blocked.
IP 3 -dependent Ca 2؉ release is required for glucose uptake and GLUT4 translocation in cardiomyocytes
Although there is evidence in both adipocytes and skeletal muscle that Ca 2ϩ may play a role in insulin stimulation of glucose uptake (16, 17) , the underlying mechanisms are unresolved, and moreover it is not known whether this occurs in cardiomyocytes. Uptake of [ 3 H]2-deoxyglucose was significantly elevated by insulin in cells incubated in Ca 2ϩ -containing or Ca 2ϩ -free media. Glucose uptake increased during the first minutes of insulin stimulation, reaching values 3.2 Ϯ 0.2 and 3.5 Ϯ 0.3 times higher than the control, in the presence and absence of extracellular Ca 2ϩ , respectively (Supplemental Fig. 6A ). Cytochalasin B markedly reduced insulin-stimulated glucose uptake in both extracellular Ca 2ϩ conditions (Supplemental Fig. 6A ), confirming that glucose uptake occurred through GLUT-mediated transporters. Indinavir (100 M), a blocker of glucose influx through GLUT4 (36), inhibited insulin-stimulated glucose uptake to reach basal values, suggesting that GLUT4 is the preeminent pathway for glucose uptake in insulin-stimulated cardiomyocytes (Supplemental Fig. 6A ).
Neither nifedipine nor ryanodine affected the insulindependent stimulation glucose uptake, whether in Ca 2ϩ -containing or Ca 2ϩ -free media, suggesting that stimulation does not require extracellular Ca 2ϩ influx or Ca 2ϩ release through RyR (Supplemental Fig. 6B) . Notably, however, insulin-stimulated glucose uptake was com- pletely inhibited by BAPTA-AM, Ad␤ARK-ct, U-73122, and 2-APB and was also partially inhibited by siRNA to type 2 IP 3 R (Fig. 3, A-C) . These results strongly suggest that insulin-dependent stimulation of glucose uptake requires the second-phase Ca 2ϩ transient, which was similarly sensitive to these selective inhibitors of the G␤␥-PLC-IP 3 R axis. Interestingly, the insulin-dependent stimulation of glucose uptake was not inhibited by PTX (Fig. 3A) . The results illustrated refer to cells in Ca 2ϩ -free media, and similar results were obtained in the presence of external Ca 2ϩ (data not shown). These findings suggest that glucose uptake depends on a signaling pathway involving G␤␥, PLC, type 2 IP 3 R, and Ca 2ϩ . Hence, a Ca 2ϩ -dependent signal is fundamental for the insulin-dependent stimulation of glucose uptake into cardiomyocytes. This response requires PI3K and its downstream target Akt in adipose and skeletal muscle cells, and we confirmed its role in cardiomyocytes (Fig. 3D) . The observation that both G␤␥-PLC-IP 3 R-Ca 2ϩ and PI3K-Akt inputs are required raised the question whether Ca 2ϩ might influence Akt activation. Indeed, although insulin increased Akt phosphorylation in cardiomyocytes maintained in the presence or absence of extracellular Ca 2ϩ , U-73122 and BAPTA-AM decreased the insulin-induced Akt phosphorylation in Ca 2ϩ -free media (Fig. 4A) . Moreover, the IP 3 R inhibitor 2-APB precluded insulin-dependent Akt phosphorylation (Fig. 4B) . These data reveal that the second phase of the [Ca 2ϩ ] i transient induced by insulin is required to allow Akt activation, which also requires classical input from PI 3 K (given its inhibition by LY-294002). Ultimately, mechanistic information on the stimulation of glucose uptake requires demonstration of regulation of GLUT4 translocation. To evaluate the participation of cytosolic Ca 2ϩ in the process of GLUT4 exposure at the plasma membrane, cardiomyocytes were transiently transfected with a cDNA encoding a GLUT4-myc-eGFP chimera. Insulin caused a notable and consistent 2-fold to 3-fold gain in surface GLUT4-myc at the cell surface. To demonstrate that insulin-dependent exofacial exposure of myc epitope relies on fusion of GLUT4-containing vesicles, the involvement of the vesicle soluble N-ethylmaleimide sensitive factor attachment protein receptor vesicle-associated membrane protein 2 (VAMP-2) was tested. Transfection of TeTx light chain (which proteolyses VAMP-2) completely abrogated the GLUT4 exposition (Fig. 5) .
In nonpermeabilized cells maintained in Ca 2ϩ -free medium, insulin induced a significant increase in exofacial exposure of the myc epitope. Nifedipine did not alter this response, and ryanodine only slightly decreased the insulin effect from 0.95 Ϯ 0.04 to 0.70 Ϯ 0.07 (normalized cyanine 3/eGFP ratio) (Fig. 6, A and B) . In contrast, major reductions in insulin-induced surface gain in GLUT4 were provoked by BAPTA-AM, Akt i 1/2, or the IP 3 R blocker xestospongin C. 
FIG. 4. Activation of Akt induced by insulin is dependent on the intracellular Ca
2ϩ rise. Cell lysates were separated by 10% SDS-PAGE and electrotransferred to nitrocellulose, blocked with 5% BSA, Trisbuffered saline (pH 7.6), and 0.1% Tween 20, then incubated with phospho-Akt, total-Akt, type 2 IP 3 R, or ␤-actin antibodies (1:1000 in blocking buffer), and revealed with horseradish peroxidase-linked secondary antibody (1:5000). Bands were detected using ECL and quantified by densitometry. Akt phosphorylation at Ser473 induced by 10 nM insulin for 10 min was independent of extracellular Ca Moreover, specific knockdown of type 2 IP 3 R by siRNA also markedly decreased the exofacial exposure of myc epitope induced by insulin (Fig. 6C ). These observations strongly support a role of Ca 2ϩ release through type 2 IP 3 R in GLUT4 translocation and insertion into the cardiomyocyte plasma membrane. To determine whether this mechanism is specific to insulin pathways, we studied the effect of IGF-1 and 2,4-dinitrophenol (2,4-DNP) on the exofacial exposure of myc epitope. IGF-1 (10 nM) induced a small increase in exofacial exposure of GLUT4-myc, and exposure was completely inhibited by xestospongin C (Fig. 6D) . Conversely, 2,4-DNP increased exofacial exposure of GLUT4-myc that was not inhibited by xestospongin C in cardiomyocytes maintained in Ca 2ϩ -free resting media (Fig. 6E) . These results suggest that, although free cytosolic Ca 2ϩ by itself triggers translocation/ fusion of GLUT4 with the plasma membrane, the IP 3 R-dependent release participate in specific pathways aimed to that purpose.
Finally, the involvement of ␤␥ subunits of a heterotrimeric G protein in GLUT4 translocation raised the possible participation of the ␥ isoform of PI 3 K in this process. To test this hypothesis, cardiomyocytes were cotransfected with GLUT4-myc-eGFP and WT-PI3K␥, KD-PI3K␥, or myr-PI3K␥. Remarkably, the non-active form of PI3K␥ decreased insulin-dependent exofacial exposure of myc epitope, whereas WT-PI3K␥ had no effect (Fig. 7, A and B) . Moreover, myr-PI3K␥ caused a small, if not statistically significant, elevation of the basal level of surface GLUT4-myc and also failed to inhibit insulin-mediated GLUT4-myc translocation (Fig. 7C) . As positive control, myr-Akt was shown to produce the expected gain in surface GLUT4-myc in the absence of insulin (Fig. 7D) . Together, these results support the participation of PI3K␥ in the mechanism of GLUT4 membrane translocation and insertion induced by insulin.
Discussion
Here we show a novel, insulin-induced transient increase in ] i increase involves ␤␥ subunit of a heterotrimeric G protein, PI3K␥, PLC, and type 2 IP 3 R channels. We speculate that these signals act as a linear sequence of events, The quantification was calculated as described in Materials and Methods (B). The effect of knockdown of type 2 IP 3 R in insulin-dependent exofacial exposure of myc epitope is showed in single cells (C) and quantified (D). Values represent the average Ϯ SD of four different experiments. **, P Ͻ 0.01 vs. control basal conditions. †, P Ͻ 0.05 and † †, P Ͻ 0.01 vs. insulinstimulated control condition (siNR). D, IGF-1 (10 nM) for 10 min induced a modest increase in exofacial exposure of myc epitope that was inhibited by xestospongin C (100 M). E, 2,4-DNP (0.5 mM) for 10 min induced an increase in exofacial exposure of myc epitope that was insensitive to xestospongin C (100 M) pretreatment. Values represent the average Ϯ SD of four different experiments. *, P Ͻ 0.05 and **, P Ͻ 0.01 vs. basal conditions. †, P Ͻ 0.05 and † †, P Ͻ 0.01 vs. insulin or IGF-1-stimulated condition. ‡ ‡ , P Ͻ 0.01 vs. insulin plus 2,4-DNP stimulated cardiomyocytes.
as summarized in Fig. 8 . We further show that each of the above elements is required for insulin-dependent GLUT4 translocation, revealing an unrealized connection between IP 3 R-mediated Ca 2ϩ release and insulin action. The intersection between Ca 2ϩ and the canonical PI3K-Akt insulin pathway may occur at several levels, including Ca 2ϩ -dependent facilitation of Akt activation, and potentially vesicle traffic and/or fusion with the membrane (Fig.  8) . These conclusions are expanded below.
Ca
2؉ entry pathways into the cytosol The [Ca 2ϩ ] i debate in insulin action has centered around the difficulty in detecting changes in the levels of the cation in response to the hormone. Whereas ratiometric dyes sampling the entire cytosol have failed to detect any rise in [Ca 2ϩ ] i in response to insulin in 3T3-L1 adipocytes (37), L6 myotubes (38) , and isolated skeletal muscle (39), the hormone activated the signal of a membraneassociated Ca 2ϩ sensor (FIP18) in the latter system (39 ] i produced by insulin are clearly insufficient to drive contraction.
In the heart, IP 3 is generated through the action of distinct PLCs on phosphatidylinositol 4,5-bisphosphate (40, 41) . Some neurohumoral agonists (e.g. acetylcholine, endothelin, catecholamines, prostaglandins) activate a G qdependent PLC␤ (42, 43) . In contrast, purines or angiotensin II stimulate a tyrosine kinase-dependent PLC␥ (40, 44) . IP 3 induces slow release of Ca 2ϩ from vesicular preparations and activates contraction in skinned ventricular rat muscle and chick heart preparations (45). In the adult rat, ventricular (46) and atrial (47) ] i increase induced by insulin reported here was inhibited by the expression of ␤ARK-ct, LY-294002, and type 2 IP 3 R knockdown, suggesting participation of G␤␥ subunits from heterotrimeric G protein as well as the PI 3 K and type 2 IP 3 R.
Participation of G␤␥ and PI3K␥ in insulin action in cardiomyocytes
According to the canonical insulin signaling pathway, insulin binding to its receptor activates class I PI3K (catalytic p110 ␣ and ␤ subunits) through binding of the regulatory p85 subunit to insulin receptor substrate proteins, a mechanism that is independent of G protein action. However, ␤␥ subunits of heterotrimeric G proteins can activate PI 3 K␥ by direct interaction with two domains of the catalytic p110␥ subunit (48) . During pressure load hypertrophy, PI3K is activated by a G␤␥-dependent process in mice (49) Participation of Ca 2؉ released via IP 3 R in insulin-dependent glucose uptake and GLUT4 translocation
Here we show that insulin induces an increase in glucose uptake in cardiomyocytes maintained in both Ca 2ϩ -containing and Ca 2ϩ -free resting media, suggesting that the effect of insulin is independent of extracellular Ca 2ϩ . Extracellular Ca 2ϩ also does not regulate glucose uptake in isolated working heart (51) . Although that study speculated that cytoplasmic Ca 2ϩ may not contribute to the regulation of glucose uptake in working conditions, our results clearly show that [Ca 2ϩ ] i is required for insulininduced glucose uptake in cardiomyocytes, and this effect seems to be independent of excitation-contraction [Ca 2ϩ ] i signals.
The participation of [Ca 2ϩ ] i in insulin-dependent stimulation of glucose uptake has been debated in studies using primary and cultured adipocytes, L6 myotubes, and isolated skeletal muscle. Early studies in rat adipocytes showed that, by changing extracellular Ca 2ϩ , a window of [Ca 2ϩ ] i ensued that was permissive for insulin-stimulated glucose uptake (52) , and that beyond a narrow value of 140 -270 nM, [Ca 2ϩ ] i instead correlated with insulin resistance (53). In 3T3-L1 adipocytes, as shown here for cardiomyocytes, BAPTA-AM reduced the stimulation of Akt and the gain in surface GLUT4 (16, 54) . Although neither study determine whether the hormone increases the levels of [Ca 2ϩ ] i or merely requires the resting [Ca 2ϩ ] i levels, they both showed inhibition of Akt phosphorylation, a finding we have corroborated in neonatal cardiomyocytes. Worrall and Olefsky (54) proposed that [Ca 2ϩ ] i has negative input in insulin signals proximal to the receptor and a positive input on more distal ones, including Akt. Whitehead et al. (16) further proposed two possible positive inputs for the cation based on the use of BAPTA-AM and Ca 2ϩ ionophores: one allowing the transporter to reach the plasma membrane and another one allowing its fusion with the membrane. This was ascertained from comparisons of the levels of GLUT4 associated with membrane lawns and the extent of hemagglutinin-GLUT4 epitope exposure to the outer medium. The authors presented a lucid discussion of potential molecules affected, and to date these remain attractive Ca 2ϩ targets. Finally, that study found that BAPTA-AM directly inhibited glucose uptake in adipocytes, consistent with the high susceptibility of GLUT4 to inhibition by very diverse chemical agents, which however does not invalidate the effects of BAPTA-AM on GLUT4 traffic. In contrast to these findings, a less effective chelator of intracellular [Ca 2ϩ ] i , Quin2-AM (2-[(2-bis[carboxymethyl] amino-5-methylphenoxy]-6-methoxy-8-bis[carboxymethyl]-aminoquinolinetetrakis acetoxymethyl ester), did not reduce glucose uptake in L6 myotubes or 3T3-L1 adipocytes (37, 38) , and dantrolene, an inhibitor of Ca 2ϩ release from the SER through RyRs, did not prevent GLUT4 translocation in L6 myotubes expressing GLUT4-myc (55) . Finally, in rat skeletal muscle, GLUT4 coprecipitates with the TRPC3 channel, and TRPC3 knockdown decreased in insulin-mediated glucose uptake (18) , suggesting that, in this tissue the channel, and possibly ions flowing through it, are required for insulin-stimulated glucose uptake. All these findings beg for analysis of cell-specific responses of Ca 2ϩ to insulin and for a more in depth exploration of the source of the regulatory Ca 2ϩ . In the present study, we find that this cation is likely released from endomembranes through IP 3 R and propose a signaling pathway leading to such release. This mechanism may be unique to cardiomyocytes or may be more amply operative, channel, and Ca 2ϩ release from SER. The second phase involves a non-inhibitory G proteincoupled receptor, the G␤␥ subunits that activates the lipid-kinase PI3K␥ to generate phosphatidylinositol-3,4,5-trisphosphate (PIP 3 ) from phosphatidylinositol 4,5-bisphosphate (PIP 2 ). This is a strong signal for recruitment of the pleckstrin homology domain of PLC, leading to its binding to the inner side of the cell surface. PLC then converts PIP 3 to IP 3 and diacylglycerol. IP 3 activates the IP 3 R, leading to calcium release from SER. This Ca 2ϩ is involved in GLUT4 vesicle traffic and/or fusion with the cell surface, finally producing an increase in glucose uptake. CCLT, L-type Ca 2ϩ channels; SERCA, sarcoendoplasmic reticulum Ca 2ϩ -ATPase; SR, sarcoendoplasmic reticulum.
and future work in each of the insulin-sensitive tissues should provide answers to these possibilities. We also show that either IGF-1 or 2,4-DNP can induce an increase in plasma membrane GLUT4 levels independent of the presence of extracellular Ca 2ϩ . In these conditions, the pretreatment of cardiomyocytes with xestospongin C inhibited only the effect of IGF-1. We have shown previously that IGF-1 also increases Ca 2ϩ in cardiomyocytes but with clear difference in the amplitude, frequency, duration, or subcellular localization of the Ca 2ϩ signals elicited by insulin (26) . These last findings
show that a link exists between IP 3 R-dependent Ca 2ϩ release and GLUT4 translocation, but this mechanism is particular for certain stimuli.
In particular, the link between IP 3 R-dependent Ca 2ϩ release and mobilization of GLUT4 is a novel contribution of this study. Moreover, our study provides an explanation for the documented contribution of endogenous G␣ q/11 in insulin-stimulated GLUT4 translocation in 3T3-L1 adipocytes (5) and the emulation of this process by a constitutively active form of G␣ q (Q209L-G␣ q ) acting via a PI3K-dependent mechanism (6).
The observations made in adipocytes, skeletal muscle, and ours in cardiomyocytes beg the question of what is the precise role of [Ca 2ϩ ] i that impacts on GLUT4 translocation. The regulation of Akt shown both here and by James et al. (16) may be an important point of action. Additionally, Ca 2ϩ may regulate GLUT4 vesicle fusion, potentially through interaction with molecules functionally akin to synaptotagmin. Furthermore, Ca 2ϩ ions may participate in the recently described calmodulin kinase II-dependent regulation of GLUT4 traffic (16, 33) . Future studies should reveal the molecular action of [Ca 2ϩ ] i and whether the IP 3 R implicated in this study is directly present on GLUT4 vesicles, thereby providing local levels of elevated Ca 2ϩ in the vicinity of the membrane.
In summary, insulin induces [Ca 2ϩ ] i transients in neonatal cardiomyocytes, and Ca 2ϩ release from IP 3 -sensitive stores is an important physiological regulator of the insulin-dependent stimulation of glucose uptake via GLUT4. These novel observations suggest a link between intracellular Ca 2ϩ homeostasis and metabolism and raise the concept that alterations in Ca 2ϩ regulation, so common in cardiomyopathies, may impinge on the ability of cardiomyocytes to regulate nutrient availability. Because cardiac glucose uptake is paramount for energy procurement in conditions of ischemia and hypoxia, the concomitant impairment in Ca 2ϩ fluxes may be fundamental for energy availability in the failing heart. Such a scenario would be important in cardiomyopathy accompanying insulin resistance and diabetes.
